filmov
tv
What is New on Debulking and HIPEC in Peritoneal Carcinomatosis in the Last 12 Months?
Показать описание
In this webcast from the '2019 ESMO World Congress on Gastrointestinal Cancer', Dr. Marcello Deraco discusses the latest advances in the treatment of peritoneal carcinomatosis.
© 2019 Imedex, an HMP Company
What is New on Debulking and HIPEC in Peritoneal Carcinomatosis in the Last 12 Months?
Dr. Duska on Primary Debulking Surgery in Ovarian Cancer
Dr. Karam on Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Ovarian Cancer
Dr. Comerci on the Utility of Primary Debulking Surgery in Ovarian Cancer
Dr. Salani on Patient Selection for Primary Debulking Surgery in Ovarian Cancer
Case 1: Considerations for Debulking Surgery
Dr. Wenham on Neoadjuvant Chemotherapy Versus Primary Debulking Surgery in Ovarian Cancer
Ovarian Cancer: Neoadjuvant Chemo Vs Primary Debulking
Dr. Hoffman on Primary Debulking Versus Neoadjuvant Chemotherapy in Ovarian Cancer
Secondary Debulking Surgery in Ovarian Cancer
Dr. Boisen on Scoring System for Optimal Debulking in Ovarian Cancer
Dr. Salani Discusses Neoadjuvant Chemotherapy Versus Primary Debulking Surgery in Ovarian Cancer
Debulking & Metastatic #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI
Ovarian Cancer Diagnosis & Optimal Debulking Surgery - 'WORDs of Wisdom' Dr. Dennis Ch...
Ovarian Cancer: What to Expect from Debulking Surgery
What have been the biggest breakthroughs in ovarian cancer treatment in the last 20 years?
Renal cell carcinoma
Secondary Debulking in Recurrent Ovarian Cancer
Optimal Tumor Debulking and Peritonectomy for Pseudomyxoma Peritonei | Yashoda Hospitals Hyderabad
Immunotherapy for Glioblastoma: The Most Promising Treatment Yet
Bronchoscopy - examination of your airways (English version)
Debulking regimens prior to venetoclax therapy in CLL
Secondary Debulking in Recurrent Ovarian Cancer
What is the Survival Rate of Ovarian Cancer?
Комментарии